Your browser doesn't support javascript.
loading
Quantifying the impact of gut microbiota on inflammation and hypertensive organ damage.
Avery, Ellen G; Bartolomaeus, Hendrik; Rauch, Ariana; Chen, Chia-Yu; N'Diaye, Gabriele; Löber, Ulrike; Bartolomaeus, Theda U P; Fritsche-Guenther, Raphaela; Rodrigues, André F; Yarritu, Alex; Zhong, Cheng; Fei, Lingyan; Tsvetkov, Dmitry; Todiras, Mihail; Park, Joon-Keun; Markó, Lajos; Maifeld, András; Patzak, Andreas; Bader, Michael; Kempa, Stefan; Kirwan, Jennifer A; Forslund, Sofia K; Müller, Dominik N; Wilck, Nicola.
Afiliación
  • Avery EG; Experimental and Clinical Research Center, A Cooperation of Charité-Universitätsmedizin Berlin and Max-Delbrück-Center for Molecular Medicine, Berlin, Germany.
  • Bartolomaeus H; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
  • Rauch A; DZHK (German Centre for Cardiovascular Research), partner site Berlin, Germany.
  • Chen CY; Department of Biology, Chemistry, and Pharmacy, Freie Universität Berlin, Berlin, Germany.
  • N'Diaye G; Experimental and Clinical Research Center, A Cooperation of Charité-Universitätsmedizin Berlin and Max-Delbrück-Center for Molecular Medicine, Berlin, Germany.
  • Löber U; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
  • Bartolomaeus TUP; DZHK (German Centre for Cardiovascular Research), partner site Berlin, Germany.
  • Fritsche-Guenther R; Department of Nephrology and Internal Intensive Care Medicine, Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Rodrigues AF; Experimental and Clinical Research Center, A Cooperation of Charité-Universitätsmedizin Berlin and Max-Delbrück-Center for Molecular Medicine, Berlin, Germany.
  • Yarritu A; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
  • Zhong C; DZHK (German Centre for Cardiovascular Research), partner site Berlin, Germany.
  • Fei L; Department of Nephrology and Internal Intensive Care Medicine, Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Tsvetkov D; Experimental and Clinical Research Center, A Cooperation of Charité-Universitätsmedizin Berlin and Max-Delbrück-Center for Molecular Medicine, Berlin, Germany.
  • Todiras M; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
  • Park JK; DZHK (German Centre for Cardiovascular Research), partner site Berlin, Germany.
  • Markó L; Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Maifeld A; Experimental and Clinical Research Center, A Cooperation of Charité-Universitätsmedizin Berlin and Max-Delbrück-Center for Molecular Medicine, Berlin, Germany.
  • Patzak A; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
  • Bader M; Charité-Universitätsmedizin Berlin, Corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Kempa S; Experimental and Clinical Research Center, A Cooperation of Charité-Universitätsmedizin Berlin and Max-Delbrück-Center for Molecular Medicine, Berlin, Germany.
  • Kirwan JA; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
  • Forslund SK; DZHK (German Centre for Cardiovascular Research), partner site Berlin, Germany.
  • Müller DN; Experimental and Clinical Research Center, A Cooperation of Charité-Universitätsmedizin Berlin and Max-Delbrück-Center for Molecular Medicine, Berlin, Germany.
  • Wilck N; Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association, Berlin, Germany.
Cardiovasc Res ; 119(6): 1441-1452, 2023 06 13.
Article en En | MEDLINE | ID: mdl-35904261
ABSTRACT

AIMS:

Hypertension (HTN) can lead to heart and kidney damage. The gut microbiota has been linked to HTN, although it is difficult to estimate its significance due to the variety of other features known to influence HTN. In the present study, we used germ-free (GF) and colonized (COL) littermate mice to quantify the impact of microbial colonization on organ damage in HTN. METHODS AND

RESULTS:

4-week-old male GF C57BL/6J littermates were randomized to remain GF or receive microbial colonization. HTN was induced by subcutaneous infusion with angiotensin (Ang) II (1.44 mg/kg/day) and 1% NaCl in the drinking water; sham-treated mice served as control. Renal damage was exacerbated in GF mice, whereas cardiac damage was more comparable between COL and GF, suggesting that the kidney is more sensitive to microbial influence. Multivariate analysis revealed a larger effect of HTN in GF mice. Serum metabolomics demonstrated that the colonization status influences circulating metabolites relevant to HTN. Importantly, GF mice were deficient in anti-inflammatory faecal short-chain fatty acids (SCFA). Flow cytometry showed that the microbiome has an impact on the induction of anti-hypertensive myeloid-derived suppressor cells and pro-inflammatory Th17 cells in HTN. In vitro inducibility of Th17 cells was significantly higher for cells isolated from GF than conventionally raised mice.

CONCLUSION:

The microbial colonization status of mice had potent effects on their phenotypic response to a hypertensive stimulus, and the kidney is a highly microbiota-susceptible target organ in HTN. The magnitude of the pathogenic response in GF mice underscores the role of the microbiome in mediating inflammation in HTN.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Microbiota / Microbioma Gastrointestinal / Hipertensión Tipo de estudio: Clinical_trials Idioma: En Revista: Cardiovasc Res Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Microbiota / Microbioma Gastrointestinal / Hipertensión Tipo de estudio: Clinical_trials Idioma: En Revista: Cardiovasc Res Año: 2023 Tipo del documento: Article